Kelly C. Chambliss serves as Independent Director of the Company. Ms. Chambliss as served as a director since September 2016. Ms. Chambliss has been the General Manager and Managing Partner of the Distribution and Industrial Sectors within IBM Global Business Services (GBS) North America since April 2018. Prior to this role, beginning in October 2013, Ms. Chambliss served as the Global Chief Technology Officer for IBM GBS, with a focus on the development, marketing, sales, and delivery of cloud-based solutions. Ms. Chambliss served in various other roles at IBM from late 2002 to October 2013. Ms. Chambliss joined IBM in late 2002 through the acquisition of PricewaterhouseCoopers Consulting, where she was a Partner. Ms. Chambliss graduated from Virginia Tech with a degree in Management Science and a specialization in Decision Support Systems. In determining Ms. Chambliss' qualifications to serve on our Board, the Board considered, among other things, Ms. Chambliss' significant experience in the technology and technology consulting industries, which provides us with valuable insight into the technology and market trends that affect our industry.
As the Independent Director of Cencora, the total compensation of Kelly Chambliss at Cencora is $275,013. There are 9 executives at Cencora getting paid more, with Paul Szurek having the highest compensation of $5,385,070.
Kelly Chambliss is 49, she's been the Independent Director of Cencora since 2016. There are 12 older and 2 younger executives at Cencora. The oldest executive at Cencora Inc. is David Wilson, 79, who is the Lead Independent Director.
Kelly's mailing address filed with the SEC is 116, Huntington Avenue, Back Bay, Boston, Suffolk County, Massachusetts, 02116, United States.
Over the last 14 years, insiders at Cencora have traded over $67,682,023 worth of Cencora stock and bought 34,206 units worth $1,080,918 . The most active insiders traders include Realty Iii, Gp, L.L.C.Carly..., Iv Aiv Gp, L.L.C.Crp Iv Aiv..., eGroup Management L.L.C.Carl.... On average, Cencora executives and independent directors trade stock every 13 days with the average trade being worth of $18,365,869. The most recent stock trade was executed by Brian Warren on 5 November 2021, trading 850 units of COR stock currently worth $130,577.
amerisourcebergen is driving innovative partnerships with global manufacturers, providers and pharmacies to improve product access and efficiency throughout the healthcare supply chain and enhance patient care. as the leader in global sourcing and distribution, we source and distribute brand, generic, specialty, otc pharmaceuticals and other healthcare products. we increase the effectiveness and efficiency of your supply chain by ensuring products are delivered securely, consistently and cost-effectively, improving product access for pharmacies, providers and patients. our pharmacy solutions result in greater operational efficiency, cost control, growth opportunities and patient safety. our provider solutions drive operational efficiency, financial performance and improve quality of care. our manufacturer solutions maximize success at every stage of the product lifecycle. amerisourcebergen. where knowledge, reach and partnership shape healthcare delivery.
Cencora executives and other stock owners filed with the SEC include: